Article metrics

Download PDFPDF

ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation


Online download statistics by month:

Online download statistics by month: April 2022 to December 2022

Apr 202233763
May 202220162
Jun 2022576165
Jul 202227959
Aug 2022204117
Sep 202228221130
Oct 202226422234
Nov 202216912624
Dec 202219155